Surgery in the tri-modality treatment of small cell lung cancer.Stage-dependent survival | Zendy

A Granetzny | Zendy; A.-W. A. Boseila | Zendy; William Wagner | Zendy; G KRUKEMEYER | Zendy; U Vogt | Zendy; E. Hecker | Zendy; Olaf Koch | Zendy; F. Klinke | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Surgery in the tri-modality treatment of small cell lung cancer.Stage-dependent survival

Author(s) -

A Granetzny,

A.-W. A. Boseila,

William Wagner,

G KRUKEMEYER,

U Vogt,

E. Hecker,

Olaf Koch,

F. Klinke

Publication year - 2006

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1016/j.ejcts.2006.05.002

Subject(s) - medicine , surgery , radiation therapy , thoracotomy , chemotherapy , stage (stratigraphy) , lung cancer , regimen , mediastinal lymph node , pneumonectomy , cancer , metastasis , paleontology , biology

Patients with small cell lung cancer (SCLC) are frequently denied surgical treatment despite growing body of evidence for a longer duration of remission and overall survival, if surgical intervention is integrated in a tri-modality therapy concept including chemotherapy, surgery, and radiotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research